​

Cencora (COR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

COR Stock Forecast

Cencora (COR) stock forecast, based on 46 Wall Street analysts, predicts a 12-month average price target of $373.17, with a high of $415.00 and a low of $330.00. This represents a 8.42% increase from the last price of $344.18.

$200 $250 $300 $350 $400 $450 High: $415 Avg: $373.17 Low: $330 Last Closed Price: $344.18

COR Stock Rating

Cencora stock's rating consensus is Buy, based on 46 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 31 Buy (67.39%), 14 Hold (30.43%), 1 Sell (2.17%), and 0 Strong Sell (0.00%).

Buy
Total 46 1 14 31 Strong Sell Sell Hold Buy Strong Buy

COR Price Target Upside V Benchmarks

TypeNameUpside
StockCencora8.42%
SectorHealthcare Stocks 15.45%
IndustryMedical Distribution Stocks9.27%

Price Target Trends

1M3M12M
# Anlaysts1710
Avg Price Target$400.00$372.71$358.10
Last Closing Price$344.18$344.18$344.18
Upside/Downside16.22%8.29%4.04%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 251104-116
Nov, 251104-116
Oct, 251105--16
Sep, 251105--16
Aug, 251104-116
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 08, 2025Barclays$400.00$337.8218.41%16.22%
Nov 07, 2025Kevin CaliendoUBS$415.00$363.5814.14%20.58%
Nov 06, 2025Evercore ISI$400.00$352.1313.59%16.22%
Oct 30, 2025Steven ValiquetteMizuho Securities$340.00$333.172.05%-1.21%
Oct 27, 2025UBS$380.00$334.0013.77%10.41%
Oct 16, 2025Steven ValiquetteMizuho Securities$334.00$319.614.50%-2.96%
Oct 08, 2025Evercore ISI$340.00$308.7110.14%-1.21%
Aug 13, 2025Stephen BaxterWells Fargo$354.00$289.1522.43%2.85%
Jul 16, 2025Erin WrightMorgan Stanley$330.00$295.6811.61%-4.12%
Apr 15, 2025Erin WrightMorgan Stanley$288.00$284.541.22%-16.32%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 08, 2025BarclaysUnderweightOverweightinitialise
Nov 06, 2025Evercore ISIOutperformOutperformhold
Oct 27, 2025UBSBuyBuyhold
Aug 13, 2025Wells FargoOverweightOverweighthold
Jun 03, 2025Wells FargoEqual-WeightOverweightupgrade
Dec 04, 2024Bank of America SecuritiesNeutralNeutralhold
Sep 18, 2024CitigroupBuyBuyhold
Sep 06, 2024Wells FargoEqual-WeightEqual-Weighthold
Aug 26, 2024Cowen & Co.BuyBuyhold
Aug 21, 2024Leerink PartnersUnderperformUnderperformhold

Financial Forecast

EPS Forecast

$0 $5 $10 $15 $20 $25 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$7.48$8.15$8.62$7.60$8.03----
Avg Forecast$9.23$2.78$11.93$13.65$15.16$16.59$18.15$20.68$22.96
High Forecast$9.47$3.33$11.95$13.67$15.46$17.17$20.01$21.30$23.65
Low Forecast$8.79$2.23$11.90$13.60$14.89$16.13$16.40$20.26$22.49
Surprise %-18.96%193.17%-27.75%-44.32%-47.03%----

Revenue Forecast

$0 $100B $200B $300B $400B $500B Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$213.99B$238.59B$262.17B$293.96B$321.33B----
Avg Forecast$212.20B$708.52M$259.67B$292.54B$320.22B$340.96B$363.69B$404.37B$443.83B
High Forecast$216.34B$850.22M$261.65B$293.25B$324.52B$348.77B$364.51B$413.74B$454.12B
Low Forecast$204.32B$566.81M$257.87B$291.78B$316.92B$334.75B$362.87B$398.07B$436.91B
Surprise %0.84%33574.22%0.96%0.49%0.35%----

Net Income Forecast

$0 $1B $2B $3B $4B $5B Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$1.54B$1.70B$1.75B$1.51B$1.55B----
Avg Forecast$82.85M$91.14M$1.87B$2.73B$3.04B$3.33B$3.65B$4.14B$4.60B
High Forecast$99.43M$109.37M$2.24B$2.74B$3.10B$3.44B$4.01B$4.27B$4.74B
Low Forecast$66.28M$72.91M$1.49B$2.72B$2.98B$3.23B$3.28B$4.06B$4.51B
Surprise %1758.59%1763.96%-6.52%-44.74%-48.86%----

COR Forecast FAQ

Is Cencora stock a buy?

Cencora stock has a consensus rating of Buy, based on 46 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 31 Buy, 14 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Cencora is a favorable investment for most analysts.

What is Cencora's price target?

Cencora's price target, set by 46 Wall Street analysts, averages $373.17 over the next 12 months. The price target range spans from $330 at the low end to $415 at the high end, suggesting a potential 8.42% change from the previous closing price of $344.18.

How does Cencora stock forecast compare to its benchmarks?

Cencora's stock forecast shows a 8.42% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical distribution stocks industry (9.27%).

What is the breakdown of analyst ratings for Cencora over the past three months?

  • December 2025: 6.25% Strong Buy, 62.50% Buy, 25.00% Hold, 0% Sell, 6.25% Strong Sell.
  • November 2025: 6.25% Strong Buy, 62.50% Buy, 25.00% Hold, 0% Sell, 6.25% Strong Sell.
  • October 2025: 6.25% Strong Buy, 62.50% Buy, 31.25% Hold, 0% Sell, 0% Strong Sell.

What is Cencora’s EPS forecast?

Cencora's average annual EPS forecast for its fiscal year ending in September 2026 is $16.59, marking a 106.60% increase from the reported $8.03 in 2025. Estimates for the following years are $18.15 in 2027, $20.68 in 2028, and $22.96 in 2029.

What is Cencora’s revenue forecast?

Cencora's average annual revenue forecast for its fiscal year ending in September 2026 is $340.96B, reflecting a 6.11% increase from the reported $321.33B in 2025. The forecast for 2027 is $363.69B, followed by $404.37B for 2028, and $443.83B for 2029.

What is Cencora’s net income forecast?

Cencora's net income forecast for the fiscal year ending in September 2026 stands at $3.33B, representing an 114.57% increase from the reported $1.55B in 2025. Projections indicate $3.65B in 2027, $4.14B in 2028, and $4.6B in 2029.